Evidence map›Paper›PMID 32368002›Full record

ArticleMolecular vision2020

Clinical, histopathological, and in silico pathogenicity analyses in a pedigree with familial amyloidosis of the Finnish type (Meretoja syndrome) caused by a novel gelsolin mutation.

Jesus Cabral-Macias, Leopoldo A Garcia-Montaño, Mario Pérezpeña-Díazconti, Marisa-Cruz Aguilar, Guillermo Garcia, Carlos I Vencedor-Meraz, Enrique O Graue-Hernandez, Oscar F Chacón-Camacho, Juan C Zenteno

Open access · greenAbstract readCase Reports
In one paragraph

Article in Molecular vision, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. A molecular perspective of gelsolin amyloidosis: An old foe with new faces.Cellular and molecular life sciences : CMLS · 2026
    Review
  3. Review
  4. Journal of neurology, neurosurgery, and psychiatry · 2023
    Article
  5. Article
  6. Article
  7. Systemic diseases and the cornea.Experimental eye research · 2021
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jesus Cabral-MaciasDepartment of Cornea, Institute of Ophthalmology "Conde de Valenciana," Mexico City, Mexico.
Leopoldo A Garcia-MontañoResearch Unit, Institute of Ophthalmology "Conde de Valenciana," Mexico City, Mexico.
Mario Pérezpeña-DíazcontiPathology Department, Institute of Ophthalmology "Conde de Valenciana," Mexico City, Mexico.
Marisa-Cruz AguilarResearch Unit, Institute of Ophthalmology "Conde de Valenciana," Mexico City, Mexico.
Guillermo GarciaDepartment of Cornea, Institute of Ophthalmology "Conde de Valenciana," Mexico City, Mexico.
Carlos I Vencedor-MerazVector Borne Disease Program, Secretaría de Salud Pública, Hermosillo, Sonora, Mexico.
Enrique O Graue-HernandezDepartment of Cornea, Institute of Ophthalmology "Conde de Valenciana," Mexico City, Mexico.
Oscar F Chacón-CamachoResearch Unit, Institute of Ophthalmology "Conde de Valenciana," Mexico City, Mexico.
Juan C ZentenoResearch Unit, Institute of Ophthalmology "Conde de Valenciana," Mexico City, Mexico.
Institute of Ophthalmology · MXUniversidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Familial amyloidosis of the Finnish type (FAF) is an inherited amyloidosis arising from mutations in the gelsolin protein (GSN). The disease includes facial paralysis, loose skin, and lattice corneal dystrophy. To date, FAF has been invariably associated with substitution of Asp214 in GSN. We describe the clinical, histopathological, and genetic features of a family with FAF due to a novel GSN mutation. Methods: Five affected adult individuals in a three-generation FAF pedigree were included in the study. Histopathological analysis was performed on an eyelid skin biopsy from one patient. Genetic analysis included next-generation sequencing (NGS) and Sanger sequencing for confirmation of the Results: Three older adult affected patients exhibited corneal lattice dystrophy, cutis laxa, and facultative peripheral neuropathy. Two younger adult individuals presented only with corneal amyloid deposits. NGS identified a heterozygous Conclusions: The results expand the molecular spectrum of GSN-linked systemic amyloidosis. The novel p.Met544Arg pathogenic variant is predicted to affect gelsolin function, presumably by impairing a potential calcium-sensitive, actin-binding region.

Indexed as

AdultAmyloidAmyloid Neuropathies, FamilialBiopsyCorneal Dystrophies, HereditaryCutis LaxaEyelidsFamilyFemaleGelsolinHeterozygoteHigh-Throughput Nucleotide SequencingHumansMaleMiddle AgedMutationAmyloidGelsolin

Identifiers

PMID32368002
PMCPMC7195602
OpenAlexW3023642395

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.